← Back to all trials
Not Yet Recruiting
NCT07736040
The Impact of Diabetes Remission on Aging
Conditions: Type 2 Diabetes
Sex: All
Ages: 35 Years – 70 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 100
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Summary
This study is a real-world, prospective clinical cohort study. It will enroll Chinese patients with type 2 diabetes. The aim is to assess the changes in aging biomarkers, primarily DunedinPACE, from baseline to post-remission, and to compare these biomarkers between patients who achieve successful remission and those who do not.
Eligibility Criteria
Inclusion Criteria:
1. Age 35 to 70 years.
2. Diagnosis of type 2 diabetes mellitus according to WHO criteria, with disease duration ≤6 years.
3. HbA1c between 7.0% and 9.5%, OR currently on glucose-lowering medications.
4. Fasting C-peptide ≥1.0 ng/mL.
5. Fasting plasma glucose \
Source: ClinicalTrials.gov (NCT07736040). StuddyBuddy aggregates publicly available trial information.
